Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04770272
Title Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy (neoMono)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Palleos Healthcare GmbH

triple-receptor negative breast cancer


Atezolizumab + Carboplatin + Paclitaxel

Atezolizumab + Cyclophosphamide + Epirubicin


Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.